Phibro Animal Health | PAHC - Selling And Administration Expenses

Stock Price
52.26
Daily Change
0.99 1.93%
Monthly
31.08%
Yearly
102.79%
Q1 Forecast
12.72

Phibro Animal Health reported $76.34M in Selling and Administration Expenses for its fiscal quarter ending in December of 2024.





Selling And Administration Expenses Change Date
Align Technology USD 441.68M 23.88M Dec/2025
ANI Pharmaceuticals USD 76.66M 5.11M Sep/2025
Assertio Holdings USD 16.73M 1.66M Sep/2024
Aurora Cannabis CAD 41.79M 3.84M Sep/2025
Bristol-Myers Squibb USD 2.18B 392M Dec/2025
Canopy Growth CAD 29.53M 999K Sep/2025
Corcept Therapeutics USD 106.97M 3.12M Sep/2025
Eli Lilly USD 3.13B 391.3M Dec/2025
Henry Schein USD 760M 17M Sep/2025
Idexx Laboratories USD 275.68M 10.58M Dec/2025
Knight Therapeutics CAD 25.48M 119K Sep/2024
Merck USD 2.85B 215M Dec/2025
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Pacira USD 91.8M 14.6M Sep/2025
Phibro Animal Health USD 76.34M 10.54M Dec/2024
Prestige Brands USD 29.67M 1.64M Dec/2025
Supernus Pharmaceuticals USD 179.68M 117.46M Sep/2025
Zoetis USD 619M 40M Dec/2025